PTC Therapeutics
PTCT
PTCT
206 hedge funds and large institutions have $2.94B invested in PTC Therapeutics in 2019 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 67 increasing their positions, 60 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
+22
Holders Change %
+11.96%
% of All Funds
4.07%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
57
Increased
67
Reduced
60
Closed
33
Calls
$53.6M
Puts
$44.4M
Net Calls
+$9.2M
Net Calls Change
-$1.74M
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$41.3M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$30.1M |
| 3 |
AC
Armistice Capital
New York
|
+$29.9M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.8M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19.5M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$55.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$54.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$37.1M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$33.8M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$29.5M |
